Next 10 |
home / stock / lly / lly articles
In a significant development in the battle against Alzheimer’s disease, the U.S. Food and Drug Administration (FDA) has approved Eli Lilly an...
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory, i...
The President of the United States, Joe Biden, and Sen. Bernie Sanders, the Senate Chairman of the Health, Education, Labor, and Pensions Committee...
In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry obse...
Novo Nordisk A/S (NYSE:NVO) plans to limit initial sales of its obesity treatment Wegovy in China as the Danish drugmaker faces the challenge of ba...
Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry’s, are not worried about the impact of weight-loss drugs on their ice crea...
In a new study published in the JAMA Network Open medical journal, Novo Nordisk A/S’s (NYSE:NVO) Saxenda (liraglutide), an earlier-generation...
On Tuesday, Eli Lilly and Co (NYSE:LLY) announced a collaboration with Microsoft Corp (NASDAQ:MSFT)-backed OpenAI that will allow Lilly to lev...
Eli Lilly and Co (NYSE:LLY) shares are moving higher Monday following the release of positive Phase 3 trial results for its weight loss drug, tirze...
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 16:00:05 ET Terence Flynn from Morgan Stanley issued a price target of $1,023.00 for LLY on 2024-07-02 14:30:00. The adjusted price target was set to $1,023.00. At the time of the announcement, LLY was trading at $906.1521. The overall price target consensus i...
Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease PR Newswire Kisunla slowed cognitive and functional decline by up to 35% compared to placebo at 18 months in its pivotal Phase 3 study and reduced participan...
A look at the top 10 most actives in the United States Senti Biosciences Inc. (SNTI) rose 51.3% to $0.4175 on volume of 386,768,896 shares NVIDIA Corporation (NVDA) rose 0.6% to $124.3 on volume of 277,459,318 shares PROSHARES TRUST (SQQQ) fell 1.9% to $8.12 on volume of 139,088,335 share...